DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
Companies / Juvena Therapeutics, Inc.
Juvena Therapeutics, Inc.
Unlocking the therapeutic potential of secreted proteins Restoring tissue health and rejuvenating lives Protein signaling dysregulation leads to degenerative diseases Juvena maps the therapeutic potential of natural secreted proteins and engineers them into biologics that restore tissue homeostasis Restoring tissue health by repairing protein signaling and intercellular communication Secreted proteins are released by cells to […]
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 1
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 1
Financing history
1 rounds
- Jun 27, 2025Form D equity offering · $30.5M (form d sold) · 12 investorsFact SEC EDGAR Form D data sets (quarterly) · “Juvena Therapeutics, Inc. filed Form D: $30,493,884 sold of $41,000,000, Other Technology”
Investors on record
1 edges
- Compound Advisors, LLC portfolio listing Fact compound.vc
People
1 officers, 7 directors
- Hanadie Yousef Executive Officer/Director sec.gov
- Steven James Director Fact
- Ben Hemani Director Fact
- Stephen Juelsgaard Director Fact
- Laura Lande-Diner Director Fact
- Christopher Kirk Director Fact
- Ayman Alabdallah Director Fact
- Jeremy O'Connell Director Fact
Timeline
1
- Jul 25, 2025Juvena Therapeutics, Inc. filed Form D: $30,493,884 sold of $41,000,000, Other TechnologyForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
19 observations
Every observation on this company
- Description: Unlocking the therapeutic potential of secreted proteins Restoring tissue health and rejuvenating lives Protein signaling dysregulation leads to degenerative diseases Juvena maps the therapeutic potential of natural secreted proteins and engineers them into biologics that restore tissue homeostasis Restoring tissue health by repairing protein signaling and intercellular communication Secreted proteins are released by cells to […] Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)
- Entity type: Corporation Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Other Technology Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): Decline to Disclose Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: overFiveYears Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $30.5M Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $41.0M Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-06-27 Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 12 Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 640 GALVESTON DRIVE, REDWOOD CITY, CA, 94063 Jul 25, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Listed on portfolio page: Compound Advisors, LLC Sep 16, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Listed on portfolio page: Compound Advisors, LLC Sep 14, 2026 Fact Venture organization websites (about, team, portfolio, thesis, news pages)
- Website status: ok Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)
- Site title: Home - Juvena Therapeutics Sep 14, 2026 Fact Portfolio company websites (about, investors, press pages)